Trial intelligence / Profile preview

Betamethasone vs Methylprednisolone for Trigger Finger Flare Reactions

NCT04900220Phase 4Completed

Sponsor
West Virginia University
Start
Sep 2021
Primary completion
Dec 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in trigger finger comparing Betamethasone Arm with Methylprednisolone Arm (2 arms). Primary endpoints: Incidence of Pain at 7 days, Intensity of Pain at 7 days and 1 more. Started Sep 2021; status: completed.

02

Drugs

betamethasonemethylprednisolone
03

Conditions

trigger finger

Beyond the preview

Go deeper on NCT04900220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04900220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call